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Editorial
Challenges in healthcare provision
Advances in medicine have resulted in decreased neonatal 
and child mortality  and greater longevity in the developed 
countries. However a declining birth rate has resulted in a 
significant proportion of the population being the retired 
and the elderly. Infectious diseases no longer pose a major 
health threat in the developed as opposed to the developing 
countries with the former showing an exponential increase 
in the prevalence of chronic non communicable disease, the 
associated morbidity proving a huge burden on healthcare 
budgets. 
Obesity, diabetes mellitus and cardiovascular disease top 
the list of chronic non-communicable diseases. This issue 
includes an assessment of the care provided patients suffering 
from Type II Diabetes Mellitus in a primary health care setting 
and analyses the quality of care provided as measured by 
the ability to meet targets in disease control. Much has been 
achieved but so much more needs to be done. The author 
concludes that patient education and empowerment is 
crucial to improving outcomes in chronic disease. Naturally 
ensuring access to multidisciplinary care, medications and 
regular screening for complications remains important. 
Such care however does not and should not be the remit of 
tertiary centres but must and should devolve to community 
care. At a professional level, the establishment of  guidelines 
for the follow up and management of chronic disease such 
as diabetes would aid healthcare providers to ensure that 
health care delivery in the community is evidence-based and 
that standards of quality care are adhered to and attained. 
On a national level, a public health campaign should educate 
the public as to the services available  in the community 
and  develop the concept that should problems arise, then 
there is scope for referral to a tertiary referral centre. The 
review article on Charcot’s arthropathy, a complication 
of uncontrolled diabetes highlights the need for access to 
specialised care. The loss of productivity related to the 
onset of complications of diabetes, and indeed other chronic 
diseases, is deleterious to a country’s economy and hence the 
focus should remain primary prevention. Whilst it may seem 
appreciably difficult to justify allocation  of  a significant 
proportion of healthcare budgets to primary prevention, 
the long-term benefit to patients AND healthcare providers 
have been proven again and again.1  The recommendation is 
that three times a country’s gross national income per capita 
is cost-effective. Furthermore with respect to secondary 
prevention, for example, achievement of glycaemic and blood 
pressure control in rural India decreased the prevalence of 
chronic kidney disease at a cost of 43 US cents per capita of 
the population.2 There is no reason why Malta should not 
be able to achieve the same targets. Cutajar reports that 
HbA
1c
 level was controlled in 37. 3%, systolic blood pressure 
was controlled in 44. 5%, cholesterol was controlled in 30% 
while LDL was controlled in 10.9 % of patients. Considering 
that all patients suffering from diabetes mellitus have a 
constitutional right to free medication, then surely we can 
increase the percentage of patients achieving glycaemic and 
blood pressure targets. 
With respect to diabetes, but certainly also in all chronic 
non-communicable diseases, global equity in healthcare 
provision remains one of the major challenges that healthcare 
professionals and providers have to face but perhaps we can 
learn from past experience. Why is it that for example a low 
income country such as Costa Rica can achieve the same 
rate of renal transplant as a high income country such as 
Norway?3 There are surely lessons to be learnt here in terms 
of the management of chronic disease. Even more important 
is the fact that studies have shown that the annual cost of 
maintaining a patient with a renal transplant is 25-33 per 
cent that of maintaining a patient on dialysis.  The recipients’ 
quality of life is significantly improved and their economic 
productivity is re-instated. 
The evidence, is overwhelming be it for diabetes, heart 
disease4 or indeed other chronic non-communicable disease. 
The time for an in-depth analysis of what plagues healthcare 
is long overdue. Global equity in healthcare appears to remain 
the dream of those who are idealists but there are success 
stories out there and not necessarily in countries with a 
high GDP. Observation represents one of the fundamental 
principles of the scientific method coupled with analysis 
of outcomes, the solutions to the challenges that plague 
healthcare delivery become evident. An injection of resources 
is necessary but the long-term benefits to the community  and 
the healthcare providers more than justify the expenditure. 
The burning question remains: Who has the foresight, and 
the courage to embark on this particular journey? 
Josanne Vassallo
Editor
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